Back to Forecasting
DOWActive

Will DOW disclose a Transform to Outperform run-rate exceeding $1.0B cost savings by Q2 2026 earnings?

Resolves August 1, 2026(101d)
IG: 0.60

Current Prediction

55%
Likely Yes
Model Agreement92%
Predictions9 runs
Last UpdatedApril 22, 2026

Why This Question Matters

Transform to Outperform is the single most-monitored operational program across four independent lenses. A $1.0B run-rate disclosure by Q2 2026 earnings would confirm execution trajectory toward the $1.5-1.8B realistic delivery range and validate the cycle-recovery framing. A sub-$1B disclosure (or silence on run-rate) would trigger simultaneous downgrades across stress-scanner, roadkill-radar, myth-meter, and moat-mapper assessments. This market directly tests the load-bearing assumption in the thesis.

OPERATIONAL_EXECUTIONEXPECTATIONS_PRICEDCOMPETITIVE_POSITION

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 50%62%Aggregate: 55%
Individual Predictions(9 runs)
opusRun 1
58%

Company's own stated cadence is $1B run-rate by end-2026. Q2 2026 earnings (~late July / early August) would be the natural disclosure window. Run-rate disclosures are softer than realized savings — they count actions that are 'locked in' even if P&L hasn't flowed through. Given that $400M was delivered by mid-2025, 4,500-role cuts announced in late 2025 / early 2026, and European rationalization underway, $1B locked-in run-rate by Q2 2026 earnings is achievable. Management has strong communication incentive given DEMANDING expectations priced and Carter transition.

Company target is $1B run-rate end-2026Run-rate softer than realizedStrong management incentive to disclose
opusRun 2
55%

The $1B target is end-2026, and the question asks for disclosure by 2026-08-01 (essentially Q2 earnings, one quarter ahead of schedule). Management may pace disclosures to avoid over-promising: Q1 2026 earnings could show $700-800M run-rate, Q2 could show $850-950M, then Q4 $1B+. The question's bar is achievable but requires pulled-forward disclosure vs natural cadence. I see ~55% probability because Fitterling's outgoing-year narrative benefits from early $1B disclosure even if timing is ahead of target.

Question asks one quarter ahead of $1B targetManagement pacing vs outgoing-year narrativeFitterling incentive favors early disclosure
opusRun 3
62%

Four independent lenses treat T2O as load-bearing and the committee is watching for $1B run-rate by Q2 earnings. Committee's realistic estimate was $1.5-1.8B delivery vs $2B target. A $1B run-rate by mid-2026 is consistent with that trajectory. Risk to YES: management hedges with ranges ('$900M-$1.1B') that resolve ambiguously. Risk to NO: execution slippage on European permitting or severance timing. Balance: 60-65%.

Realistic delivery $1.5-1.8B supports $1B mid-2026 run-rateRange disclosures may blur exact $1B barExecution risk contained
sonnetRun 1
55%

Company's explicit cadence is $1B run-rate by end-2026. Disclosure by 2026-08-01 (Q2 earnings) is one quarter ahead of target. Management will have pressure to demonstrate progress given DEMANDING priced expectations. The 4,500-role cut announced 2026-01-29 and European rationalization provide the structural foundation. Most likely Q2 disclosure is $800M-$1.1B range. Exact $1B bar is approximately coin-flip with upside lean.

One quarter ahead of targetStructural actions locked inCoin-flip around exact $1B bar
sonnetRun 2
50%

Run-rate disclosure language is typically cumulative and carefully phrased. Question resolves YES if DOW discloses 'run-rate exceeding $1B' by Q2 earnings. Management may prefer to disclose 'approaching $1B' or 'on track to exceed $1B by year-end' — which would resolve NO. Literal threshold compliance is strict. I see this as ~50% probability.

Literal threshold compliance strictManagement may use 'approaching' languageResolution criteria interpretation risk
sonnetRun 3
58%

Combined signal from mid-2025 delivery ($400M raised from $300M), late 2025 / early 2026 structural actions (4,500 roles, European shutdowns), and Q2 2026 disclosure timing: trajectory supports $1B run-rate disclosure. Upside bias from incoming-CEO optics (Carter takes over July 2026; Fitterling wants clean handoff narrative). ~60% probability.

Trajectory supports $1B disclosureCarter transition creates clean-handoff incentiveStructural actions locked in
haikuRun 1
55%

Company target $1B run-rate by end-2026. Q2 2026 earnings is natural disclosure window, slightly ahead of target. Structural actions (4,500-role cut, European closures) provide foundation. ~55% probability given typical management communication pacing.

$1B target end-2026Q2 disclosure window ahead of targetCommunication pacing
haikuRun 2
52%

$1B run-rate is the end-2026 target. Hitting it by Q2 disclosure requires pulled-forward realization. Structural actions in early 2026 provide some basis. Coin-flip with slight upside lean given Carter transition incentive.

Pulled-forward targetStructural actions provide basisCEO transition incentive
haikuRun 3
58%

Combined view: $400M mid-2025 baseline, structural actions in Q4 2025 / Q1 2026, and target $1B end-2026. By Q2 earnings (mid-2026), run-rate disclosure of $1B is achievable but not certain. Probability ~55-60%.

$400M baseline + structural actionsEnd-2026 target within sightAchievable but not certain

Resolution Criteria

Resolves YES if DOW discloses a Transform to Outperform (or successor program) cumulative run-rate cost savings / EBITDA uplift figure exceeding $1.0B in a Q1 2026 or Q2 2026 earnings release, earnings call, or 10-Q filed by 2026-08-01. Resolves NO if no such disclosure is made or if the figure is below $1.0B.

Resolution Source

DOW Q1 / Q2 2026 earnings releases, earnings call transcripts, 10-Q filings

Source Trigger

DOW discloses Transform to Outperform run-rate > $1.0B cost savings

roadkill-radarOPERATIONAL_EXECUTIONHIGH
View DOW Analysis

Full multi-lens equity analysis